Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Recruiting now · Phase 1/Phase 2
Conditions studied: HIV Infection
In brief
The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among infants living with HIV.
Key facts
- Study ID
- NCT02140255
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 1120
- Starts
- 2015-01-23
- Expected to finish
- 2031-12-31
- Last updated by the study team
- 2026-08-06
Who can join
Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.
Where it is running
- 5092, Johns Hopkins Clinical Research Site — Baltimore, Maryland, United States (enrolling)
- 5048, University of Southern California Clinical Research Site — Los Angeles, California, United States (enrolling)
- 5112, David Geffen School of Medicine at UCLA Clinical Research Site — Los Angeles, California, United States (enrolling)
- 5052, University of Colorado, Denver Clinical Research Site — Aurora, Colorado, United States (enrolling)
- 5051, University of Florida Center for HIV/AIDS Research, Education and Service (UF CARES) Clinical Research Site — Jacksonville, Florida, United States (enrolling)
- 4001, Lurie Children's Hospital of Chicago Clinical Research Site — Chicago, Illinois, United States (enrolling)
- 5114, Bronx Lebanon Hospital Center Clinical Research Site — The Bronx, New York, United States (enrolling)
- 5013, Jacobi Medical Center Clinical Research Site — The Bronx, New York, United States (enrolling)
- 6501, St Jude Children's Research Hospital Clinical Research Site — Memphis, Tennessee, United States (enrolling)
- 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site — Houston, Texas, United States (enrolling)
- 5073, School of Medicine Federal University Minas Gerais Clinical Research Site — Minas Gerais, Brazil (enrolling)
- 5071, Instituto de Puericultura e Pediatria Martagao Gesteira Clinical Research Site — Rio de Janeiro, Brazil (enrolling)
- 30022, Les Centres GHESKIO Clinical Research Site — Port-au-Prince, Haiti (enrolling)
- 5121, Kenya Medical Research Institute/Walter Reed Project Clinical Research Center Kericho Clinical Research Site — Kericho, Kenya (enrolling)
- 12001, Malawi Clinical Research Site — Lilongwe, Central Region, Malawi (enrolling)
- 30301, Blantyre Clinical Research Site — Blantyre, Malawi (enrolling)
- 30300, Umlazi Clinical Research Site — Durban, KwaZulu-Natal, South Africa (enrolling)
- 5118, Kilimanjaro Christian Medical Centre Clinical Research Site — Moshi, Tanzania (enrolling)
- 5115, Siriraj Hospital Mahidol University Clinical Research Site — Bangkok, Bangkoknoi, Thailand (enrolling)
- 5116, Chiangrai Prachanukroh Hospital Clinical Research Site — Chiang Mai, Thailand (enrolling)
- 31798, Baylor-Uganda Clinical Research Site — Kampala, Uganda (enrolling)
- 30303, Saint Mary's Clinical Research Site — Chitungwiza, Zimbabwe (enrolling)
- 30306, Seke North Clinical Research Site — Chitungwiza, Zimbabwe (enrolling)
- 31890, Harare Family Care Clinical Research Site — Harare, Zimbabwe (enrolling)
- Soweto IMPAACT CRS — Johannesburg, Gauteng, South Africa
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.